GlassScriptPhysician profile
Jonathan R Oldaker
NPI 1154881795
$1,616.13
in general payments reported to CMS, 2019-2025
18 companies · $347 in 2025
The $347 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $61.73 · 2022: $109 · 2023: $446 · 2024: $653 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,445.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $344.60 | 2023-2025 | Breztri, Airsupra, Farxiga |
| Abbvie INC. | $269.23 | 2021-2024 | |
| Lilly USA, LLC | $207.31 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $169.54 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $111.01 | 2023-2025 | Xifaxan, Trulance |
| Daiichi Sankyo INC. | $96.63 | 2023-2025 | Injectafer |
| Pfizer INC. | $87.83 | 2023-2025 | |
| Astellas Pharma US INC | $69.41 | 2023-2024 | Veozah, Myrbetriq |
| Xeris Pharmaceuticals, INC. | $48.47 | 2022-2024 | Gvoke Hypopen |
| Ipsen Biopharmaceuticals, INC | $35.50 | 2025 | |
| Exact Sciences Corporation | $34.81 | 2024-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $30.53 | 2024 | Trelegy Ellipta |
| Edwards Lifesciences Corporation | $30.13 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Dynavax Technologies Corporation | $20.37 | 2024 | Heplisav-B |
| Merck Sharp & Dohme LLC | $16.89 | 2023 | Verquvo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.79 | 2024 | Ofev |
| Phathom Pharmaceuticals, INC. | $14.82 | 2025 | Voquezna |
| Dexcom, INC. | $12.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Oldaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.